The State of the Healthcare Industry and the Impact on Investment Banking/Capital Markets

Wednesday, January 29, 2020

4:00–7:00 p.m. ET

INOVA Conference Center
8100 Innovation Park Dr.
Falls Church, VA 22042

Register Now

Cost: Members $25 & Non-Members $45

Cocktails and hors d'oeuveres will be served. CPE Credits Available.

Meet your speakers


Christopher Helmrath, Managing Director, SC&H Capital

Christopher Helmrath preaches that everything the practice does needs to be about what is in the best of the client, and that the root of everything is in the strategy to exceed every clients’ expectations. But it’s not only the client who Helmrath and the SC&H Capital team has top of mind—they will never let a referral partner down.


Industry Panel

Deanne Kasim, Executive Director – Health Policy, Change Healthcare

Deanne Kasim has built a career on helping various organizations navigate and leverage evolving changes in technology, policy, regulation, and market dynamics. In her current role with Change Healthcare, Kasim interprets legislative, regulatory, and industry trends to drive business decisions and inform product strategy and roadmaps.

Dan Zohorsky, Director – Corporate Development, CareFirst BlueCross BlueShield – Healthworx

Dan Zohorsky is a Director at CareFirst BlueCross BlueShield and leads acquisition and partnership initiatives within Healthworx, the corporate venture and corporate development arm of CareFirst. Dan and the Healthworx team engage with companies across the healthcare ecosystem both within the CareFirst communities of Maryland, Washington DC, and northern Virginia and across the country. Healthworx is currently building a portfolio of investments and evaluating strategic acquisitions and partnerships with companies that address the needs of CareFirst and its members today and whose solutions have the potential to make a substantial impact in healthcare three to five years down the road.

Prior to joining Healthworx, Dan was a Strategy Director in Anthem’s Diversified Business Group (DVB), responsible for the development of M&A and partnership strategy. Prior to Anthem, Dan worked in a corporate development role at W.R. Grace and in investment banking with SunTrust Robinson Humphrey. Dan has extensive experience evaluating and negotiating acquisitions, joint venture and other strategic transactions across multiple industries.

Dan graduated from University of Maryland (BA) and Georgetown University (MBA). He lives in Baltimore with his wife and three children.

Eric Victory, VP- Biopharmaceuticals Business Development, AstraZeneca

Eric Victory is VP, Biopharmaceuticals Business Development for AstraZeneca, based in Gaithersburg, MD. He has held a variety of business development roles within AstraZeneca and MedImmune since 2006, including responsibility covering the company’s infectious disease and cardiovascular, renal, and metabolism therapeutic areas. Eric also managed the company’s US Government pandemic flu contracting, and was initially a part of the MedImmune commercial team. Prior to his time with MedImmune and AstraZeneca, Eric was a commissioned officer in the US Navy Nuclear Propulsion Program. He holds bachelors degrees from Stanford University and an MBA from Northwestern University’s Kellogg School of Management.


Investment Banking/Capital Markets Panel

Richard A. Bendis, President & CEO, BioHealth Innovation, Inc.

Rich Bendis currently serves as the founding President and CEO of BioHealth Innovation, a Maryland public-private partnership focused on accelerating the growth of commercially relevant science. He is also the founding President and CEO of Innovation America, a national public-private partnership focused on accelerating the growth of innovation economy in America.

David LaMacchia, Principal, NaviMed Capital

David LaMacchia has over 17 years’ healthcare transactional, investing, and operational experience. Prior to joining NaviMed Capital, LaMacchia led M&A transactions in the physician services sector at Prospira PainCare, a national provider of interventional pain management services, and U.S. Anesthesia Partners, a national anesthesia services practice.

Navid Farzad, Partner, Frist Cressey Ventures

Prior to joining Frist Cressey Ventures, Navid Farzad was a partner with Morgan Noble, an investment firm exclusively focused on partnering with companies that are determined to transform the delivery of healthcare. Farzad also served as the Chief Strategy Officer of Continuum Health, a physician enablement company providing practice management and population health services to medical groups.

Register Now

DC/MD/VA Committee

Brent Solomon, CM&AA, Principal, Strategic Financial Advisory,

Brittany Adams, Director, Venue Deal Solutions, DFIN

Taylor Devine, CM&AA, Founder/Managing Partner, The CDI Group

Ted Lauer, SVP, Atlantic Union Bank

Scott Meza, Shareholder, Greenberg Traurig

Tom Neale, Partner, Murray Hill

Peter Ryan, Partner, Ryan & Wetmore, PC

Kim Clark Pakstys, Managing Director, BDO USA, LLP

Event Sponsors

Learn More!
Your message was successfully sent!

9 + 8 =